Weekly Research Analysts’ Ratings Changes for Bioceres Crop Solutions (BIOX)

A number of firms have modified their ratings and price targets on shares of Bioceres Crop Solutions (NASDAQ: BIOX) recently:

• 9/11/2024 – Bioceres Crop Solutions had its price target lowered by analysts at Oppenheimer Holdings Inc. from $17.00 to $16.00. They now have an “outperform” rating on the stock.
• 9/11/2024 – Bioceres Crop Solutions had its price target lowered by analysts at Canaccord Genuity Group Inc. from $17.00 to $12.50. They now have a “buy” rating on the stock.
• 9/11/2024 – Bioceres Crop Solutions had its price target lowered by analysts at Roth Mkm from $15.00 to $13.00. They now have a “buy” rating on the stock.
• 9/11/2024 – Bioceres Crop Solutions had its price target lowered by analysts at Lake Street Capital from $25.00 to $13.00. They now have a “buy” rating on the stock.

Bioceres Crop Solutions Stock Down 1.5 %

BIOX opened at $7.85 on Monday. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. Bioceres Crop Solutions Corp. has a twelve month low of $7.74 and a twelve month high of $14.05. The stock has a market capitalization of $492.96 million, a price-to-earnings ratio of 785.00 and a beta of 0.49. The firm has a 50 day moving average price of $9.84 and a 200-day moving average price of $11.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The firm had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same period last year, the company earned ($0.06) earnings per share. Equities research analysts forecast that Bioceres Crop Solutions Corp. will post 0.39 earnings per share for the current year.

Institutional Investors Weigh In On Bioceres Crop Solutions

Large investors have recently added to or reduced their stakes in the stock. Oppenheimer & Co. Inc. bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth $139,000. Lazard Asset Management LLC bought a new stake in Bioceres Crop Solutions during the 1st quarter valued at $212,000. Ping Capital Management Inc. purchased a new stake in shares of Bioceres Crop Solutions in the 2nd quarter worth $448,000. Sumitomo Mitsui Trust Holdings Inc. bought a new position in shares of Bioceres Crop Solutions during the 2nd quarter worth $472,000. Finally, Dimensional Fund Advisors LP increased its stake in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares during the period. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.